NASDAQ:NBIX
Neurocrine Biosciences Stock News
$140.48
+1.08 (+0.775%)
At Close: May 28, 2024
Assertio (ASRT) to Report Q2 Earnings: What's in the Cards?
04:20pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Assertio Holdings' (ASRT) second-quarter performance is likely to reflect the sales performance of its marketed drugs and cost savings from the company's restructuring plans.
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy?
02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Neurocrine (NBIX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has Lyra Therapeutics (LYRA) Outpaced Other Medical Stocks This Year?
01:40pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Here is how Lyra Therapeutics, Inc. (LYRA) and Neurocrine Biosciences (NBIX) have performed compared to their sector so far this year.
What's in Store for United Therapeutics' (UTHR) Q2 Earnings?
02:13pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
United Therapeutics' (UTHR) investor focus is likely to have been on sales figures of Tyvaso, Remodulin and Orenitram in the second quarter, as these constitute a vast majority of the total revenues.
What to Expect From Molina Healthcare's (MOH) Q2 Earnings?
03:35pm, Monday, 25'th Jul 2022 Zacks Investment Research
Molina Healthcare's (MOH) second-quarter results are likely to reflect benefits from higher premiums stemming from Medicaid and Medicare businesses, partly offset by elevated medical care costs.
10 Best Low-Volatility Stocks to Buy Now
02:01pm, Monday, 25'th Jul 2022
The stock market is suffering a turbulent 2022 so far – and with inflation still running at a 40-year high, the Federal Reserve locked in a significant rate-hiking cycle and midterm elections just m
Here's How Universal Health (UHS) Looks Ahead of Q2 Earnings
04:29pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
Universal Health's (UHS) second-quarter results are likely to benefit from sound contributions from Acute Care Hospital Services segment. Increased labor costs might partly hurt results.
Better Ingrezza Sales And A Clinical Trial Read-Out Could Reignite Neurocrine Shares
11:22pm, Monday, 18'th Jul 2022
Neurocrine should soon release Phase II data on NBI-827104, and a positive read-out on a largely overlooked drug today could add 5% to 10% to NBIX's fair value. Between the expansion of the sales forc
Factors Likely to Shape Tenet Healthcare's (THC) Q2 Earnings
03:34pm, Monday, 18'th Jul 2022 Zacks Investment Research
Tenet Healthcare's (THC) second-quarter results are likely to reflect the impact of lower contribution of the Hospital segment to overall revenues. The results might partly benefit from a downtrend in
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
10:20am, Friday, 15'th Jul 2022 Zacks Investment Research
Sector ETF report for FBT
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2022 Financial Results
04:01pm, Thursday, 14'th Jul 2022
Conference Call and Webcast Scheduled for Thursday, August 4 SAN DIEGO , July 14, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it will report second quarter 2
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
10:20am, Thursday, 07'th Jul 2022 Zacks Investment Research
Smart Beta ETF report for FBT
Neurocrine Biosciences to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
04:01pm, Wednesday, 08'th Jun 2022
SAN DIEGO , June 8, 2022 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 43rd Annual Global Healthcare Conference at 10:40 a.m. Pacific Time (1:40 p.m.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
10:20am, Tuesday, 10'th May 2022 Zacks Investment Research
Sector ETF report for FBT
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
10:20am, Friday, 06'th May 2022 Zacks Investment Research
Smart Beta ETF report for FBT
